CD55-deficient Protein-losing Enteropathy
3 clinical trials · Condition
◉ Watch CD55-deficient Protein-losing Enteropathy
| Record | Firm | Date |
|---|---|---|
| Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease) (NCT04209634) | Regeneron Pharmaceuticals | 2020-01-27 |
| Compassionate Use of Pozelimab (NCT05232110) | Regeneron Pharmaceuticals | |
| Compassionate Use of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (NCT06003881) | Regeneron Pharmaceuticals |
Track CD55-deficient Protein-losing Enteropathy automatically
Every clearance here is in the API, with alerts when new ones post.